In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Baxter Oncology Brand of Etoposide Drug Master File in Korea (Baxter Oncology Brand of Etoposide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Baxter Oncology Brand of Etoposide. The MFDS reviews the Baxter Oncology Brand of Etoposide KDMF as part of the drug registration process and uses the information provided in the Baxter Oncology Brand of Etoposide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Baxter Oncology Brand of Etoposide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Baxter Oncology Brand of Etoposide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Baxter Oncology Brand of Etoposide suppliers with KDMF on PharmaCompass.